Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Semax

PeptideResearch peptide

Useful mainly for not established — investigational.

Research compound — not an approved drug or dietary supplement

This compound is sold for research and is not FDA-approved for human use or as a dietary supplement. Human evidence is limited; purity and dosing of consumer products are unverified. The data below is an evidence review for education only — talk to a clinician before considering it.

Quick decision guide

May help most

Not established — investigational

Watch out for

Not FDA-approved; limited independent human evidence and unregulated research-grade purity

What is it

Semax is a synthetic peptide based on a fragment of adrenocorticotropic hormone (ACTH 4-10), developed in Russia and proposed to have neuroprotective and nootropic effects by modulating BDNF and other neurotrophic signaling. It is registered and used as a medication in Russia (e.g., as a nasal drop) for certain neurological indications, but it is not FDA-approved in the United States and has not been validated in large independent controlled trials outside Russian-language literature. Evidence is largely preclinical and limited regional clinical use; it is not a dietary supplement and is sold in the West only 'for research use only.'

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Probably skip if…

You expect an FDA-approved or independently validated nootropic — it is neither
You would buy from 'research use only' vendors with no purity or sterility controls
You are not prepared for unknown long-term safety outside limited regional use
You are uncomfortable that most efficacy data come from non-replicated, single-region literature
You want to avoid legal gray areas around importing unapproved drugs

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Reported in limited use: generally described as mild; possible nasal irritation with intranasal use. Not well characterized in independent trials

Serious risks

  • Unregulated purity, sterility, and dosing of research-grade product

  • Unknown long-term neurological and hormonal effects (ACTH-fragment origin)

  • Lack of independent safety monitoring or validated dosing

  • Possible contamination in non-pharmaceutical research-grade material

Who should avoid it

  • Anyone using it without direct medical supervision
  • Pregnancy and breastfeeding
  • People with psychiatric or neurological conditions (without supervision)
  • Anyone relying on it in place of evaluated medical treatment

Pregnancy & breastfeeding

Avoid — no safety data.

Choosing a product

What to look for on the label — and what to be skeptical of.

Be skeptical of…

'Proven' cognitive-enhancement or neuroprotection claims for the general public
Vendors selling 'for research use only' product for human use
Implying U.S. approval or equivalence to evaluated nootropic medications

Track Semax with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: This compound is not approved by the FDA for human use and is not a dietary supplement. This page is an educational review of available research — much of it preclinical or early-stage — not a recommendation to use it. Consumer product quality is unregulated. Consult a qualified clinician.